Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 1.5B | 1.6B | 1.8B | 1.5B |
Cost of revenue | 264.7M | 260.3M | 266.8M | 252.9M |
Gross profit | 1.3B | 1.3B | 1.5B | 1.2B |
Operating expense | ||||
Research & development | 348.7M | 348.6M | 327.7M | 321M |
Selling general and admin | 571.8M | 566.9M | 593M | 521.2M |
Other operating expenses | -1.9M | 4.4M | — | 4.2M |
Operating income | 252.9M | 304.4M | 483.5M | 276.1M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | — | — | — | — |
Pretax income | 271.5M | 334.8M | 506.3M | 308.2M |
Tax provision | 52.9M | 75.5M | 95.4M | 68.5M |
Net income | 218.5M | 259.4M | 410.9M | 239.8M |
Basic EPS | 0.2 | 0.2 | 0.3 | 0.2 |
Diluted EPS | 0.2 | 0.2 | 0.3 | 0.2 |
Basic average shares | 1.3B | 1.3B | 1.3B | 1.3B |
Diluted average shares | 1.3B | 1.3B | 1.3B | 1.3B |
EBITDA | 457.7M | 444.5M | 622.6M | 415.8M |
Net income from continuing op. | 218.5M | 259.4M | 412M | 239.8M |
Minority interests | 4.9M | 1.2M | 1.1M | 0 |
Preferred stock dividends | 0 | 0 | 0 | 0 |